DRC starts Ebola vaccine rollout for frontline healthcare workers

Ebola cases linked to the Bundibugyo strain continue to surface in the Democratic Republic of the Congo (DRC), prompting authorities to intensify containment efforts. In response, clinical trials for a vaccine specifically targeting this strain are underway, aiming to curb transmission and protect healthcare workers and high‑risk populations.

The trials, conducted in partnership with international health agencies, are designed to assess the vaccine’s safety, immunogenicity, and efficacy under field conditions. Early phases have recruited volunteers in regions most affected by the outbreak, while monitoring protocols track adverse events and immune responses over several months.

As the DRC government implements enhanced surveillance, contact tracing, and community education campaigns, the vaccine trials represent a critical component of the broader strategy to halt the spread of Ebola. Successful outcomes could provide a targeted tool for future outbreaks of the Bundibugyo strain and strengthen the country’s epidemic preparedness.